SCHEMBL9989115

SCHEMBL9989115

Cn1ccc(-n2cc3ccc(C(N)=O)cc3n2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 2/20 0.42
▸ MKNK2 Q9HBH9 2/20 0.42
▸ KMT2A Q03164 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ PLK1 P53350 1/20 0.37
▸ PLK2 Q9NYY3 1/20 0.37
▸ NSD2 O96028 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ JAK2 O60674 5/20 0.36
▸ JAK1 P23458 5/20 0.36
▸ TYK2 P29597 5/20 0.36
▸ JAK3 P52333 5/20 0.36
▸ STING1 Q86WV6 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ BRD4 O60885 1/20 0.35
▸ BRPF1 P55201 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TGFBR1 P36897 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9989118 0.80 KDM4E (0.57) MKNK1MKNK2KMT2AKDM4EALDH1A1
SCHEMBL17112018 0.75 MAPT (0.55) KMT2AKDM4EALDH1A1MAPTJAK2
SCHEMBL29633279 0.74 ADORA3 (0.42) KMT2AKDM4EALDH1A1JAK2JAK1
SCHEMBL28201512 0.68 MAOA (0.54) MKNK1MKNK2KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL28856319 0.67 MAOA (0.53) MKNK1MKNK2KMT2AKDM4EALDH1A1
SCHEMBL21604623 0.66 MAPT (0.54) KDM4EALDH1A1NSD2MAPTBRD4
SCHEMBL4264874 0.66 KDM4E (0.54) KMT2AKDM4EALDH1A1NSD2MAPT
SCHEMBL9991288 0.66 NPC1 (0.60) KDM4EALDH1A1NSD2MAPTSMN1; SMN2
SCHEMBL29750942 0.66 KDM4E (0.50) KMT2AKDM4EALDH1A1JAK2JAK1
SCHEMBL30186922 0.65 MAPT (0.53) KDM4EALDH1A1NSD2MAPTJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110319379-A1 Substituted Indazole Amides And Their Use As Glucokinase Activators CORBETT JEFFREY W (US) 2011-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319379-A1 Substituted Indazole Amides And Their Use As Glucokinase Activators GCKR, GCK, GALK1 MKNK1 214/4885MKNK2 151/4885KMT2A 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback